Jynneos | search
Click here to view Jynneos news from 60+ newspapers.
Bookmark or Share- About Smallpox Vaccines - CDCACAM2000® and JYNNEOS TM (also known as Imvamune or Imvanex) are the only two licensed smallpox vaccines in the United States. Aventis Pasteur Smallpox Vaccine (APSV) is an investigational vaccine that may be used in a smallpox emergency under the appropriate regulatory mechanism (i.e., Investigational New Drug application [IND] or Emergency ...
- JYNNEOS | FDA - U.S. Food and Drug AdministrationIndicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.
- Mpox Vaccination | Mpox | CDCJYNNEOS is a 2-dose vaccine developed to protect against mpox and smallpox. People need to get both doses of the vaccine for the best protection against mpox. The second dose should be given 4 weeks after the first dose.
- Mpox Vaccine Recommendations - SanDiegoCounty.govJYNNEOS is a 2-dose vaccine that was developed to protect against mpox and smallpox. You can choose to get the JYNNEOS vaccine injected under your skin in the upper arm (subcutaneous) or in the skin layer beneath the top layer of your skin (intradermal).
- Smallpox/Monkeypox Vaccine Information Statement | CDCSmallpox/monkeypox vaccine (JYNNEOS ™) is made using weakened live vaccinia virus and cannot cause smallpox, monkeypox, or any other infectious disease. JYNNEOS ™ is approved by the Food and Drug Administration (FDA) for prevention of smallpox and monkeypox disease in adults 18 years or older at high risk for smallpox or monkeypox infection .
More
